| Primary |
| Diabetes Mellitus |
31.3% |
| Type 2 Diabetes Mellitus |
31.3% |
| Hypertension |
9.0% |
| Blood Pressure |
3.0% |
| Vitamin Supplementation |
3.0% |
| Blood Cholesterol |
2.2% |
| Blood Glucose |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Anticoagulant Therapy |
1.5% |
| Atrial Fibrillation |
1.5% |
| Blood Cholesterol Increased |
1.5% |
| Coagulopathy |
1.5% |
| Dyspnoea |
1.5% |
| Glucose Tolerance Impaired |
1.5% |
| Migraine |
1.5% |
| Pain |
1.5% |
| Supplementation Therapy |
1.5% |
| Arrhythmia |
0.7% |
| Arterial Disorder |
0.7% |
| Benign Prostatic Hyperplasia |
0.7% |
|
| Pancreatitis |
26.9% |
| Pancreatic Carcinoma |
14.8% |
| Rash |
6.5% |
| Drug Ineffective |
4.6% |
| Headache |
4.6% |
| Blood Glucose Increased |
3.7% |
| Drug Dose Omission |
3.7% |
| Weight Decreased |
3.7% |
| Weight Increased |
3.7% |
| Blood Triglycerides Increased |
2.8% |
| Diabetes Mellitus Inadequate Control |
2.8% |
| Medication Residue Present |
2.8% |
| Nausea |
2.8% |
| Pruritus |
2.8% |
| Renal Failure |
2.8% |
| Urticaria |
2.8% |
| Vomiting |
2.8% |
| Abdominal Discomfort |
1.9% |
| Angioedema |
1.9% |
| Blood Creatine Phosphokinase Increased |
1.9% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
40.0% |
| Asthma |
8.0% |
| Hypertension |
8.0% |
| Blood Cholesterol |
4.0% |
| Cardiac Disorder |
4.0% |
| Chronic Obstructive Pulmonary Disease |
4.0% |
| Diabetic Neuropathy |
4.0% |
| Gastrooesophageal Reflux Disease |
4.0% |
| Haemorrhoids |
4.0% |
| Pain |
4.0% |
| Polyuria |
4.0% |
| Prophylaxis |
4.0% |
| Rheumatoid Arthritis |
4.0% |
| Sleep Disorder |
4.0% |
|
| Glycosylated Haemoglobin Increased |
22.2% |
| Diarrhoea |
11.1% |
| Hypertension |
11.1% |
| Injection Site Pain |
11.1% |
| Injection Site Pruritus |
11.1% |
| Rheumatoid Arthritis |
11.1% |
| Therapeutic Response Decreased |
11.1% |
| Weight Decreased |
11.1% |
|
| Concomitant |
| Type 2 Diabetes Mellitus |
72.1% |
| Diabetes Mellitus |
4.7% |
| Myalgia |
4.7% |
| Blood Pressure Increased |
2.3% |
| Cystitis |
2.3% |
| Depression |
2.3% |
| Hypothyroidism |
2.3% |
| Migraine |
2.3% |
| Musculoskeletal Chest Pain |
2.3% |
| Nausea |
2.3% |
| Restless Legs Syndrome |
2.3% |
|
| Weight Decreased |
18.8% |
| Injection Site Haemorrhage |
12.5% |
| Vomiting |
12.5% |
| Accidental Overdose |
6.3% |
| Drug Effect Decreased |
6.3% |
| Dysgeusia |
6.3% |
| Flatulence |
6.3% |
| Injection Site Pruritus |
6.3% |
| Injection Site Swelling |
6.3% |
| Pyrexia |
6.3% |
| Somnolence |
6.3% |
| Underdose |
6.3% |
|
